Association of CRP and IL-6 with lung function in a middle-aged population initially free from self-reported respiratory problems: The Whitehall II study

European Journal of Epidemiology

Volumn 26, Issue 2, 2011, Pages 135-144

  Gimeno, David ^a,c,d,e   Delclos, George L ^b,d,e   Ferrie, Jane E ^c   De Vogli, Roberto ^c   Elovainio, Marko ^c,f   Marmot, Michael G ^c   Kivimäki, Mika ^c,g  

^a The University of Texas Health Science Center at Houston   (United States)

^b UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d UNIVERSITAT POMPEU FABRA   (Spain)

^e CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^f NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^g FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

Author keywords

Cohort study; Epidemiology; Inflammation; Pulmonary function

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; INFLAMMATION; MALE; MIDDLE AGED; PROSPECTIVE STUDY; RESPIRATORY TRACT DISEASE; SELF REPORT; UNITED KINGDOM; WHITE COLLAR WORKER;

ADULT; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; FEMALE; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; RESPIRATORY TRACT DISEASES; SELF REPORT; VITAL CAPACITY;

EID: 79954440004     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-010-9526-5     Document Type: Article

References (49)

1. HJ Schunemann J Dorn BJ Grant W Winkelstein Jr M Trevisan 2000 Pulmonary function is a long-term predictor of mortality in the general population: 29-year follow-up of the Buffalo Health Study Chest 118 3 656 664 1:STN:280:DC%2BD3cvktlGkug%3D%3D 10.1378/chest.118.3.656 10988186
2. DD Sin L Wu SF Man 2005 The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature Chest 127 6 1952 1959 10.1378/chest.127.6.1952 15947307
3. J Danesh JG Wheeler GM Hirschfield S Eda G Eiriksdottir A Rumley, et al. 2004 C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease N Engl J Med 350 14 1387 1397 1:CAS:528:DC%2BD2cXivVagsbc%3D 10.1056/NEJMoa032804 15070788 (Pubitemid 38419992)
4. GD Lowe A Rumley AD McMahon I Ford DS O'Reilly CJ Packard 2004 Interleukin-6, fibrin D-dimer, and coagulation factors VII and XIIa in prediction of coronary heart disease Arterioscler Thromb Vasc Biol 24 8 1529 1534 1:CAS:528:DC%2BD2cXmtValuro%3D 10.1161/01.ATV.0000135995.39488.6c 15205218 (Pubitemid 39050452)
5. GB Toews 2001 Cytokines and the lung Eur Respir J Suppl 34 3s 17s 1:STN:280:DC%2BD38njtlCnuw%3D%3D 10.1183/09031936.01.00266001 12392030 (Pubitemid 34760604)
6. WQ Gan SF Man A Senthilselvan DD Sin 2004 Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis Thorax 59 7 574 580 1:STN:280:DC%2BD2czkslSjsQ%3D%3D 10.1136/thx.2003.019588 15223864 (Pubitemid 38901515)
7. S Kony M Zureik F Driss C Neukirch B Leynaert F Neukirch 2004 Association of bronchial hyper responsiveness and lung function with C-reactive protein (CRP): a population based study Thorax 59 10 892 896 1:STN:280: DC%2BD2cvos1ylug%3D%3D 10.1136/thx.2003.015768 15454657 (Pubitemid 39389631)
8. AA Arif GL Delclos J Colmer-Hamood 2007 Association between asthma, asthma symptoms, and C-reactive protein in US adults Respirology 12 5 675 682 10.1111/j.1440-1843.2007.01122.x 17875055 (Pubitemid 47414878)
9. AM Sadowska B Klebe P Germonpre WA De Backer 2007 Glucocorticosteroids as antioxidants in treatment of asthma, COPD. New application for an old medication? Steroids 72 1 1 6 1:CAS:528:DC%2BD2sXis1Gjsw%3D%3D 10.1016/j.steroids.2006.10.007 17145070 (Pubitemid 46037762)
10. D Aronson I Roterman M Yigla A Kerner O Avizohar R Sella, et al. 2006 Inverse association between pulmonary function and C-reactive protein in apparently healthy subjects Am J Respir Crit Care Med 174 6 626 632 1:CAS:528:DC%2BD28XhtVOrur3N 10.1164/rccm.200602-243OC 16778162 (Pubitemid 44395328)
11. DD Sin SF Man 2006 Skeletal muscle weakness, reduced exercise tolerance, and COPD: is systemic inflammation the missing link? Thorax 61 1 1 3 1:STN:280:DC%2BD28%2FjtFOjtw%3D%3D 10.1136/thx.2005.044941 16396949 (Pubitemid 43106967)
12. R Shaaban S Kony F Driss B Leynaert D Soussan I Pin, et al. 2006 Change in C-reactive protein levels and FEV1 decline: a longitudinal population-based study Respir Med 100 12 2112 2120 10.1016/j.rmed.2006.03.027 16650972 (Pubitemid 44752671)
13. F Rasmussen D Mikkelsen RJ Hancox J Lambrechtsen M Nybo HS Hansen, et al. 2009 High-sensitive C-reactive protein is associated with reduced lung function in young adults Eur Respir J 33 2 382 388 1:CAS:528:DC%2BD1MXjvFOmtLY%3D 10.1183/09031936.00040708 19010993
14. AW Fogarty S Jones JR Britton SA Lewis TM McKeever 2007 Systemic inflammation and decline in lung function in a general population: a prospective study Thorax 62 6 515 520 10.1136/thx.2006.066969 17251312 (Pubitemid 46910130)
15. RJ Hancox R Poulton JM Greene S Filsell CR McLachlan F Rasmussen, et al. 2007 Systemic inflammation and lung function in young adults Thorax 62 12 1064 1068 10.1136/thx.2006.076877 17604302 (Pubitemid 350206198)
16. R Jiang GL Burke PL Enright AB Newman HG Margolis M Cushman, et al. 2008 Inflammatory markers and longitudinal lung function decline in the elderly Am J Epidemiol 168 6 602 610 10.1093/aje/kwn174 18687665
17. DD Sin SF Man 2003 Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease Circulation 107 11 1514 1519 10.1161/01.CIR.0000056767.69054.B3 12654609 (Pubitemid 36378490)
18. DM Mannino ES Ford SC Redd 2003 Obstructive and restrictive lung disease and markers of inflammation: data from the third national health and nutrition examination Am J Med 114 9 758 762 10.1016/S0002-9343(03)00185-2 12829203 (Pubitemid 36776358)
19. S Yende GW Waterer EA Tolley AB Newman DC Bauer DR Taaffe, et al. 2006 Inflammatory markers are associated with ventilatory limitation and muscle dysfunction in obstructive lung disease in well functioning elderly subjects Thorax 61 1 10 16 1:STN:280:DC%2BD28%2FhtFWmsA%3D%3D 10.1136/thx.2004.034181 16284220 (Pubitemid 43106971)
20. R Broekhuizen EF Wouters EC Creutzberg AM Schols 2006 Raised CRP levels mark metabolic and functional impairment in advanced COPD Thorax 61 1 17 22 1:STN:280:DC%2BD28%2FhtFWnsA%3D%3D 10.1136/thx.2005.041996 16055618 (Pubitemid 43106972)
21. VM Pinto-Plata H Mullerova JF Toso M Feudjo-Tepie JB Soriano RS Vessey, et al. 2006 C-reactive protein in patients with COPD, control smokers and non-smokers Thorax 61 1 23 28 1:STN:280:DC%2BD28%2FhtFWnsQ%3D%3D 10.1136/thx.2005.042200 16143583 (Pubitemid 43106973)
22. M Dahl J Vestbo P Lange SE Bojesen A Tybjaerg-Hansen BG Nordestgaard 2007 C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease Am J Respir Crit Care Med 175 3 250 255 1:CAS:528:DC%2BD2sXivF2kuro%3D 10.1164/rccm.200605-713OC 17053205 (Pubitemid 46203128)
23. AM Jurek G Maldonado S Greenland TR Church 2006 Exposure-measurement error is frequently ignored when interpreting epidemiologic study results Eur J Epidemiol 21 12 871 876 10.1007/s10654-006-9083-0 17186399 (Pubitemid 46197153)
24. C Gabay I Kushner 1999 Acute-phase proteins and other systemic responses to inflammation N Engl J Med 340 6 448 454 1:STN:280:DyaK1M7it1KhtA%3D%3D 10.1056/NEJM199902113400607 9971870 (Pubitemid 29084777)
25. RE Walter JB Wilk MG Larson RS Vasan JF Keaney Jr I Lipinska, et al. 2008 Systemic inflammation and COPD: the Framingham heart study Chest 133 1 19 25 1:CAS:528:DC%2BD1cXhslOku7c%3D 10.1378/chest.07-0058 17908709
26. MG Marmot GD Smith S Stansfeld C Patel F North J Head, et al. 1991 Health inequalities among British civil servants: the Whitehall II study Lancet 337 8754 1387 1393 1:STN:280:DyaK3M3ksFyksw%3D%3D 10.1016/0140-6736(91)93068-K 1674771
27. M Marmot E Brunner 2005 Cohort profile: the Whitehall II study Int J Epidemiol 34 2 251 256 10.1093/ije/dyh372 15576467 (Pubitemid 40645308)
28. GL Myers N Rifai RP Tracy WL Roberts RW Alexander LM Biasucci, et al. 2004 CDC/AHA workshop on markers of inflammation and cardiovascular disease: application to clinical and public health practice: report from the laboratory science discussion group Circulation 110 25 e545 e549 1:CAS:528: DC%2BD2MXotFentQ%3D%3D 10.1161/01.CIR.0000148980.87579.5E 15611379
29. D Gimeno EJ Brunner GDO Lowe A Rumley MG Marmot JE Ferrie 2007 Adult socioeconomic position, C-reactive protein and interleukin-6 in the Whitehall II prospective study Eur J Epidemiol 22 10 675 683 10.1007/s10654-007-9171-9 17668278 (Pubitemid 47476683)
30. MR Miller J Hankinson V Brusasco F Burgos R Casaburi A Coates, et al. 2005 Standardisation of spirometry Eur Respir J 26 2 319 338 1:STN:280:DC%2BD2MzpsFOltw%3D%3D 10.1183/09031936.05.00034805 16055882 (Pubitemid 41079078)
31. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardization of spirometry, 1994 update. American Thoracic Society. Am J Respir Crit Care Med. 1995;152(3):1107-1136.
32. M Woodward A Rumley H Tunstall-Pedoe GD Lowe 1999 Associations of blood rheology and interleukin-6 with cardiovascular risk factors and prevalent cardiovascular disease Br J Haematol 104 2 246 257 1:STN:280: DyaK1M7lsl2qsw%3D%3D 10.1046/j.1365-2141.1999.01158.x 10050704 (Pubitemid 29083330)
33. M Woodward A Rumley GD Lowe H Tunstall-Pedoe 2003 C-reactive protein: associations with haematological variables, cardiovascular risk factors and prevalent cardiovascular disease Br J Haematol 122 1 135 141 1:CAS:528:DC%2BD3sXmtVGntbk%3D 10.1046/j.1365-2141.2003.04387.x 12823355 (Pubitemid 36819348)
34. DA Lawlor S Ebrahim G Davey Smith 2004 Association between self-reported childhood socioeconomic position and adult lung function: findings from the British women's heart and health study Thorax 59 3 199 203 1:STN:280: DC%2BD2c%2Fps1agug%3D%3D 10.1136/thorax.2003.008482 14985552 (Pubitemid 38339875)
35. R Pellegrino G Viegi V Brusasco RO Crapo F Burgos R Casaburi, et al. 2005 Interpretative strategies for lung function tests Eur Respir J 26 5 948 968 1:STN:280:DC%2BD2MrosFSgtQ%3D%3D 10.1183/09031936.05.00035205 16264058 (Pubitemid 41632054)
36. Royal College of Physicians, Royal College of Psychiatrists, Royal College of General Practitioners. Alcohol and the heart in perspective: sensible limits reaffirmed. London: Royal College of Physicians, Royal College of Psychiatrists, Royal College of General Practitioners, 1995.
37. M Kumari J Head M Marmot 2004 Prospective study of social and other risk factors for incidence of type 2 diabetes in the Whitehall II study Arch Intern Med 164 17 1873 1880 10.1001/archinte.164.17.1873 15451762 (Pubitemid 39274357)
38. EJ Brunner MG Marmot K Nanchahal MJ Shipley SA Stansfeld M Juneja, et al. 1997 Social inequality in coronary risk: central obesity and the metabolic syndrome. Evidence from the Whitehall II study Diabetologia 40 11 1341 1349 1:STN:280:DyaK1c%2FkvFaqtA%3D%3D 10.1007/s001250050830 9389428 (Pubitemid 27469676)
39. E Brunner 1997 Stress and the biology of inequality BMJ 314 7092 1472 1476 1:STN:280:DyaK2szhtVCjsw%3D%3D 9167568 (Pubitemid 27207942)
40. H Kuper M Marmot 2003 Job strain, job demands, decision latitude, and risk of coronary heart disease within the Whitehall II study J Epidemiol Community Health 57 2 147 153 1:STN:280:DC%2BD3s%2Fjtlyhug%3D%3D 10.1136/jech.57.2.147 12540692 (Pubitemid 36160625)
41. MH Wener PR Daum GM McQuillan 2000 The influence of age, sex, and race on the upper reference limit of serum C-reactive protein concentration J Rheumatol 27 10 2351 2359 1:CAS:528:DC%2BD3cXnsFCqs78%3D 11036829
42. C Frost SG Thompson 2000 Correcting for regression dilution bias: comparison of method for a single predictor variable J R Stat Soc Ser A 163 173 189 10.1111/1467-985X.00164
43. G Zou 2004 A modified poisson regression approach to prospective studies with binary data Am J Epidemiol 159 7 702 706 10.1093/aje/kwh090 15033648 (Pubitemid 38405384)
44. JF Pittet RC Mackersie TR Martin MA Matthay 1997 Biological markers of acute lung injury: prognostic and pathogenetic significance Am J Respir Crit Care Med 155 4 1187 1205 1:STN:280:DyaK2s3lvVyrsQ%3D%3D 9105054 (Pubitemid 27172758)
45. M Dahl A Tybjaerg-Hansen J Vestbo P Lange BG Nordestgaard 2001 Elevated plasma fibrinogen associated with reduced pulmonary function and increased risk of chronic obstructive pulmonary disease Am J Respir Crit Care Med 164 6 1008 1011 1:STN:280:DC%2BD3MrmtFyqtg%3D%3D 11587987 (Pubitemid 32971649)
46. H Tomiyama R Okazaki Y Koji Y Usui T Hayashi S Hori, et al. 2005 Elevated C-reactive protein: a common marker for atherosclerotic cardiovascular risk and subclinical stages of pulmonary dysfunction and osteopenia in a healthy population Atherosclerosis 178 1 187 192 1:CAS:528:DC%2BD2cXhtVCltLrN 10.1016/j.atherosclerosis.2004.08.014 15585217 (Pubitemid 39600832)
47. CY Li FC Sung 1999 A review of the healthy worker effect in occupational epidemiology Occup Med (Lond) 49 4 225 229 1:STN:280:DyaK1MvgsVWlsw%3D%3D 10.1093/occmed/49.4.225 (Pubitemid 29370959)
48. Office for National Statistics. Labour Force Survey, Spring 2005. Available at: http://www.statistics.gov.uk/cci/nugget.asp?id=1654 [Accessed 17 Oct 2008], 2005.
49. KF Rabe B Beghe F Luppi LM Fabbri 2007 Update in chronic obstructive pulmonary disease 2006 Am J Respir Crit Care Med 175 12 1222 1232 1:CAS:528:DC%2BD2sXnvFakur0%3D 10.1164/rccm.200704-586UP 17545457 (Pubitemid 46905748)